| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PET | Common Stock | Award | +5.35M | 5.35M | Aug 9, 2022 | By SherpaVentures Fund II, LP | F1, F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Each share of Series B Preferred Stock and Series C Preferred Stock of Wag Labs Inc. automatically converted into shares of Wag! Group Co. Common Stock on a 1 for 0.97 basis and each share of Series P Preferred Stock of Wag Labs, Inc. automatically converted into shares of Wag! Group Co. Common Stock on a 1:1 basis in connection with the merger of Wag Labs, Inc. into CHW Merger Sub, Inc. with Wag Labs, Inc. being the surviving entity and becoming a subsidiary of Wag! Group Co. (the "Business Combination") upon the closing date of the Business Combination. |
| F2 | The reported securities are owned directly by SherpaVentures Fund II, LP. |
| F3 | The Reporting Person disclaims beneficial ownership of the securities included in this report, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. |
| F4 | The Business Combination Agreement provides that certain eligible company equity holders will receive earn-out shares as additional consideration for the Company interests acquired in connection with the business combination, for no consideration, after certain triggering events as defined in the Business Combination Agreement. The reporting person's right to receive additional shares pursuant to this earn-out right became fixed on August 9, 2022, the effective date of the Business Combination. |